Transcription of Allergen immunotherapy: A practice parameter third update
{{id}} {{{paragraph}}}
Example: confidence
Allergen immunotherapy: A practice parameter third update
Task force reportAllergen immunotherapy : a practice parameter third updateChief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MDWorkgroup Contributors: Christopher Calabria, MD, Thomas Chacko, MD, Ira Finegold, MD, Michael Nelson, MD, PhD,and Richard Weber, MDTask Force Reviewers: David I. Bernstein, MD, Joann Blessing-Moore, MD, David A. Khan, MD, David M. Lang, MD,Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher Randolph, MD, Diane E. Schuller, MD,Sheldon L. Spector, MD, Stephen Tilles, MD, and Dana Wallace, MDKeywords:Allergy immunotherapy , subcutaneous immunotherapy ,sublingual immunotherapy , allergic rhinitis, asthma, Hymenoptera,atopic dermatitis, anaphylaxis, epinephrine,b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy , in-tralymphatic immunotherapy , nasal immunotherapyThese parameters were developed by the Joint Task Force onPractice parameters , representing the American Academy ofAllergy, Asthma & Immunology (AAAAI); the American Col-lege of Allergy, Asthma & Immunology (ACAAI); and the JointCouncil of Allergy, Asthma & Immunology.
Task force report Allergen immunotherapy: A practice parameter third update Chief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MD
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: